Angioplasty Balloons Market – Future Developments and Market Outlook
The Angioplasty Balloons Market is expected to continue developing through 2035 as cardiovascular healthcare becomes increasingly focused on technology-driven and minimally invasive treatment options.
Market Research Future forecasts growth from around USD 3.38 billion in 2024 to USD 5.1 billion by 2035, corresponding to a CAGR of 3.81% during 2025–2035.
Future opportunities are closely connected to advances in medical device technology. Manufacturers are exploring improved materials, drug-eluting technologies, sophisticated balloon designs, and other innovations intended to address specific procedural requirements. The report also identifies opportunities associated with biodegradable materials and smart technologies.
Another important factor is the increasing prevalence of cardiovascular diseases. As healthcare systems respond to growing demand for cardiovascular treatment, investment in catheterization laboratories, hospitals, and other specialized facilities can support the use of angioplasty technologies.
Regional expansion may provide additional opportunities. North America currently represents a major market, while Asia-Pacific is identified as a rapidly developing region supported by healthcare expenditure and growing awareness.
The competitive environment includes companies such as Boston Scientific, Medtronic, Abbott Laboratories, B. Braun Melsungen, Cordis, Terumo, Asahi Intecc, Cook Medical, and AngioDynamics.
Overall, ongoing research, product innovation, healthcare infrastructure development, and demand for minimally invasive cardiovascular procedures are expected to remain important influences on the market through the forecast period.
Understand industry shifts with well-researched analysis:
Pompe Disease Treatment Market Forecast
Augmented Reality (AR) in Healthcare Market Outlook
Ophthalmic Equipment Market Analysis